Waiting for the next wave...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
when is the last time we had 4.5 mil volume on no news?
ELTP is becoming a normal stock.
so tempted to put you on ignore again...
He is not an hypocrite like the self crowned King.
Not worried.
Pharma, was this intended to me? Don't think so. Fat fingers?
Initially - Launch quantity should be bigger than 1 or 2 quarters after that. If the sales team is doing a good job, the next quarters should surpass the launch.
He was right Nasrat when he said that eventually the price will go up and meet reality of Elite...
He is the REAL AND ONLY KING !!!
Hi Kayak, Nice find in the transcript - however, based on what Eatman found, it seems the goods had enough time to make it to Prasco's warehouse.
Under ASC 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services.
Ok upon receipt of the goods - so what.
Back to your cave now?
No one told what is the weather in Goatland yet - can someone put his nose out of the cave for a sec?
3 million shares traded before noon - I feel good 🎵
STFU Please - it was discussed and finalized. Prasco revenues are in the safe.
Stop putting doubts in people's minds.
Goatland Honor citizen...
I crown you the New Elite King !!!
Of the day !
Here again - buyout at $1 - when we all know that it will be much higher after the 10 billion drugs will be approved and packaged by Elite...
Always putting stops...
You see? This is what I am talking about.
A self crowned King that looks at the gap at 12 cents when we look all ahead to the 20 cents gap forward.
Snow in New York, what is the temp in Goatland?
Uzo in Vegas soon
MPID ASK PRICE SIZE TIME
CDEL 0.1848 5,000 10:54
ETRF 0.185 100,000 10:28
GTSM 0.185 27,500 10:36
CFGN 0.189 5,000 09:14
NITE 0.189 5,000 10:05
INTL 0.189 5,000 11:06
OTCN 0.193 6,000 11:00
PUMA 0.20 2,500 08:00
LAFC 0.3052 2,500 08:16
CSTI 0.40 2,500 09:46
VERT 0.51 1,000 12/08
You are right - totally right.
He conveyed to me through a middleman that I would be filthy rich... (true story)
52-week range
$0.0280 - $0.1849
That would be nice - 2 to 3 cents a day cruise speed
Better from your mouth to OTC database
Cut the middleman
Pre-market - 18 cents
Please stop that !!!
STFU !!!
On is on,,,
You have to be patient Sharkey - not yet arrived in Vegas
You were wrong again!!!
Please stop the self stuff
Self crowned
Self reply
Self patting on your back
Self self self.
Embarrassing.
No fat finger here. Go back to the posts of Friday
Joebarducci posts “hold my beer for a second”
I post: “buy your tickets for the show”
Then the magic happens.
It was a deliberate action of a hero going for the FFTFC!
À demain….
If you listened to the last CC you would know Carter wanted to do them together. Less paperwork
Agree. Unless we move to Nasdaq to change the calendar year knowing growth is assured.
R/s goes hand in hand with moving to Nasdaq.
No reason for pullback. P/E ratio can double and this stock would be still undervalued
I say Vegas 2024!!!
Great news
A king does not bash his stock!!!
He protects it!!! Another proof he was an imposter from Goatland
Hyped?
Depressed!!! Manipulated!!! Kept down by force.
We can only estimate sales growth knowing we have a top sales manager who does direct sales AND develops partnerships.
Plus proof of huge penetration in the Cns market with Adderal. (Proof in the pudding)
It is not about the companies mentioned in the reply. It is more about the P/E ratio in the industry.
Trying to show that our P/e ratio is too low.
My question to ChatGPT was: what is the P/E ratio of generic pharmaceutical companies with no debt
Chat gpt 4.0:
The P/E ratio, or price-to-earnings ratio, is a measure of how much investors are willing to pay for a company’s earnings. It is calculated by dividing the market capitalization, or the total value of the company’s shares, by the net income, or the profit after taxes and interest.
The P/E ratio of generic pharmaceutical companies with no debt can vary depending on the industry, growth rate, and profitability of the company. A low P/E ratio may indicate that the company is undervalued by the market, while a high P/E ratio may indicate that the company is overvalued by the market. However, the P/E ratio alone is not enough to determine the fair value of a company, as it does not take into account the company’s revenue, expenses, assets, or growth potential. Therefore, other valuation methods, such as the dividend discount model, the discounted cash flow model, or the price/sales ratio, should also be used to complement the P/E ratio.
According to one source1, the average P/E ratio of the pharmaceutical industry as of January 2024 is 52.0, which is higher than its 3-year average of 41.6. However, this average may include companies with different levels of debt, growth, and profitability. Therefore, it is more informative to look at the P/E ratios of specific generic pharmaceutical companies with no debt.
Here are some examples of generic pharmaceutical companies with no debt and their P/E ratios as of January 20242:
Adial Pharmaceuticals (ADIL): 0.11
JanOne (JAN): 0.17
Chimerix (CMRX): 0.47
Assertio Therapeutics (ASRT): 0.48
TherapeuticsMD (TXMD): 0.49
Viatris (VTRS): 7.65
Baxter (BAX): 7.94
GlaxoSmithKline (GSK): 11.3
Johnson & Johnson (JNJ): 11.5
Pfizer (PFE): 15.9
———
We have room to grow based on what we know today. We could easily be at 68 cents per share p/e 32 (4 times today’s P/E)
At 6 times today’s P/E we should be at $1.04.
This one:
Only need about $10m in earnings (yes not revenue) a year at 10 p/e for every .10 in stock price.
They basically do that now before Prasco.
They have minimal debt.
I don't worry about whether we can make $500m a year off this drug. I'll take a few hundred million and a 50-100m in earnings. That gets you to $1 PPS and that's just this one drug.
The question that I have been asking is what are they gonna do with that profit. They have the facility, the approvals from the regulatory bodies and the know how to put tons of coal in that fire.
So using pharma s.’ Formula what price does it translate to?
Do you guys remember how hard it was to go up by a cent a year ago?
We went from 14 cents to 17 cents in 2 days!!!
Go longs go!!!
The only limitation for the next revenue is vault storage space as the new facility is not yet ready.
I put my bet on $7million more for Prasco launch.
10% growth from Kirkov and 10% price increase for adderal drought.
In the other hand increased legal fees and increased R&d cost for needle movers. Plus increased spending if we get adderall ownership from mikah.